Omada Health has started a clinical trial of its Prevent program for underserved populations in partnership with The Wellness Center at LAC+USC Medical Center in Los Angeles, Northeast Valley Health Corporation (NEVHC) in San Fernando, and a Providence Health & Services clinic in Monroe, Washington.
Taking place at three sites in California and Washington state, the trial will include up to 300 English and Spanish-language speakers who are Medicaid enrolled, Medicaid eligible, or uninsured.
Funded by the California Health Care Foundation and The Kresge Foundation, outcomes will be tracked over the course of 12 months with the help of independent evaluators, who will monitor program enrollment, participant engagement, and clinically-meaningful outcomes; assess hospital and health system data utilization; and interview provider teams for qualitative feedback.
The trial will be overseen by Omada’s Director of Medical Affairs Cynthia Castro Sweet, PhD, and Omada’s Director of Medicaid and Safety Net Commercial Development, Eliza Gibson, LCSW. Its results will be published in peer-reviewed literature in 2017.
“Omada’s mission is to inspire and enable people everywhere to live free of chronic disease; this is another step in making that mission a reality,” Omada Health co-founder and CEO Sean Duffy said in a statement. “Medicaid and uninsured populations live with disproportionate rates of chronic disease; it’s time to bring this type of life-changing intervention to anyone and everyone who needs it.”
Omada’s Prevent is a digitally-based, year-long behavioral counseling program designed to help individuals reduce their risk of type 2 diabetes and heart disease.Omada’s Prevent is a digitally-based, year-long behavioral counseling program designed to help individuals reduce their risk of certain conditions like type 2 diabetes and heart disease. It combines smart technology, a proprietary curriculum, access to a personal health coach, and a like-minded online peer network for support.
Prevent for underserved populations also includes situational and recipe awareness sensitive to food access, neighborhood safety, and economic insecurity; bilingual health coaches; and adapted curriculum for low-level literacy and English as a second language.
In addition to the three clinical trial sites, Omada Health is also currently offering Prevent for Underserved Populations to Medicaid and uninsured populations through partners Petaluma Health Center and Neighborhood Healthcare.
The company has raised $48 million Series C in September 2015.